Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | DTOISS◆ | 13,950 | — | — | — | Open the original filing on SEC.gov |
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | DTOISS◆ | 16,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | DTOISS◆ | 11,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | DTOISS◆ | 11,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | DTOISS◆ | 32,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | DTOISS◆ | 16,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | DTOISS | 25,080 | — | — | -100.0% | Open the original filing on SEC.gov |
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | UTENDR | 5,825 | $8.60 | $50.1K | -100.0% | Open the original filing on SEC.gov |